Dr. Zaks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Technology Square
Cambridge, MA 02139Phone+1 484-919-3234
Summary
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2002 - 2004
- Temple University HospitalResidency, Internal Medicine, 1999 - 2002
- Ben Gurion University of the NegevClass of 1996
Certifications & Licensure
- PA State Medical License 2002 - 2024
Publications & Presentations
PubMed
- 77 citationsIndividualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, Tarek Meniawy, George Ansstas
Lancet. 2024-02-17 - 1 citationsReport of the European Medicines Agency Conference on RNA-Based Medicines.Falk Ehmann, Andreas Kuhn, Anna Maria Gerdina Pasmooij, Anthony Humphreys, Arjon Van Hengel
Nucleic Acid Therapeutics. 2024-02-01 - 20 citationsSafety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.Allison August, Christine A Shaw, Heather Lee, Conor Knightly, Shiva Kalidindia
Open Forum Infectious Diseases. 2022-07-01
Press Mentions
- 'Israel's Vaccination Campaign Is Model for Entire World'September 24th, 2021
- Chutes & Ladders—FDA's Top Two Vaccine Leaders to Depart in the Fall as Questions Loom over Booster ShotsSeptember 3rd, 2021
- Chutes & Ladders—Ex-FDA Chief Hahn Joins Moderna BackerJune 18th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: